PERCENTAGE OF CD4+ AND CD8+ T-LYMPHOCYTES IN BLOOD OF TUBERCULOSIS PATIENTS
Abstract
Background: Tuberculosis is a fatal infectious disease, mainly caused by Mycobacteriumtuberculosis. Spread of TB is controlled by cell-mediated immunity. Purpose of this study was to
determine CD4+ and CD8+ T cell percentages in TB patients. Methods: 77 subjects consisted of
39 patients of active tuberculosis and 37 normal healthy individuals were recruited for the study.
Among patients, 27 were at different stages of anti-tuberculous therapy while rests of the patients
were not taking treatment. Sixteen patients were sputum positive for AFB while other patients
were sputum negative for AFB. T cells percentages were determined by flow cytometer. Results:
In TB patients CD4+ and CD8+ T cells percentages were 34.4±9.8 and 32.0±9.8 while in controls
these were 37.1±6.9 and 30.2±7.2 respectively but the difference was statistically insignificant.
CD4+ T cell percentage in newly diagnosed TB patients was 28.8±8.7 while it was 37.9±8.9 in TB
patients who were on therapy and difference was statistically significant whereas difference in
CD8+ T-cell percentages was statistically insignificant. A negative correlation between CD8+ Tcells percentage and the duration of ATT was found. Conclusion: CD4+ and CD8+ T-cells
percentages may help to find out the immune status of TB patients before and after the completion
of ATT.
Keywords: TB, CD4+, CD8+, ATT, AFB
References
Global Tuberculosis Control Surveillance, Planning, Financing,
Geneva: World Health Organization; 2007.
WHO report, Global tuberculosis control; TB publications,
Annex 1- Profiles of high-burden countries, Pakistan 2008. p.
Available at: http://www.who.int/tb/publications/
global_report/2008/pdf/pak.pdf
National Tuberculosis Control Program in Pakistan; Annexure I:
Historical review of TB control in Pakistan at a glance. p.15-6.
Available at: http://www.ntp.gov.pk/related_documents/
Annexure I.pdf
Aamer I, Sakhawat A, Wajid A, Muhammad AW. Latest Pattern
of Multi-drug Resistant Tuberculosis in Pakistan. Infect Dis J Pak
;17:14-7.
Carroll, Karen C. Mycobacteria. In: Brook GF, Butel JS, and Morse
SA. Jawetz, Melnick, and Adelberg's Medical Microbiology. 24th
ed. McGraw Hill; 2008:320-9.
Glickman MS, Jacobs WRJ. Microbial Pathogenesis of
Mycobacterium tuberculosis: dawn of a discipline. Cell
;104:477-85.
Rob B, Katherine F, Christopher D. Cost effective analysis of
strategies for tuberculosis control in developing countries. BMJ
;331:1-6.
Hernández-Pando R, Chacón-Salinas R, SerafÃn-López J, Estrada
I. Immunology, Pathogenesis, Virulence, In: Palomino JC, Leao
SC. Tuberculois 2007. 1st ed. Basic Science to patient care;
p.157.
Schoenborn JR, Wilson CB. Regulation of interferon-gamma
during innate and adaptive immune responses. Adv Immunol
;96:41-101.
J Ayub Med Coll Abbottabad 2010;22(4)
http://www.ayubmed.edu.pk/JAMC/PAST/22-4/Nadeem.pdf
Locksley RM, Killeen N, Lenardo MJ. The TNF, and TNF
receptor superfamilies: integrating mammalian biology. Cell
;104:487-501.
Bhatnagar R, Malaviya AN, Narayanan S, Rajgopalan P, Kumar
R. Spectrum of immune response abnormalities in different
forms of tuberculosis. The American Review of Respiratory
Disease 1977;115:207-12.
Figen D, Handan H. Lymphocyte subpopulation in pulmonary
tuberculosis patients. Mediators of inflammation 2006;10:1-6
Singhal M, Banavaliker JN. Peripheral blood lymphocytes
subpopulation in patients with tuberculosis and the effect of
chemotherapy. Tubercle 1989;70:171-8.
Pilheu JA, De Salvo MC. CD 4 lymhocytopenia in severe
pulmonary tuberculosis with out evidence of human
immunodefficiency virus infection. Int J Tuberc Lung Dis
;1:422-6.
Thomas CYT, Chihong C, Mengjer H, Kouching T, Cheng HL.
Shifts of T4/T8 T Lymphocytes from BAL Fliud and Peripheral
Blood by Clinical Grade in Patients with Pulmonary
Tuberculosis. Chest 2002;122:1285-91.
Gariby E, Gastelum PC, Velazquez C ,Hernandez J.
Immunophenotyping analysis of peripheral T and B lymphocytes
in patients with chronic pulmonary tuberculosis. International
Congress on Infectious Diseases Abstracts, Poster Presentation.
; 5:1343.
Shijubo N, Nakanishi F, Hirasawa M, Sigehara K. Sasaki H,
Asakawa M, et al. Phenotypic analysis in peripheral blood
lymphocytes of patients with pulmonary tuberculosis. Kekkaku
(Tuberculosis) 1992;67:581-5.
Vieira J, Frank E, Spira TJ, Landesman SH. Acquired immune
deficiency in Haitians: opportunistic infections in previously
healthy Haitian immigrants. N Engl J Med 1983;308:125-9.
Onwubilili JK, Edwardst AJ, Palmer L. T4 lymphopenia in
human tuberculosis. Tuercle 1987;68:195-200.
Downloads
Published
How to Cite
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.